InvestSMART

Artrya Limited (ASX: AYA) - Announcements

- Current share price for AYA : $4.690

ASX company news and announcements for Artrya Limited (AYA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Artrya Limited (AYA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Artrya Limited (AYA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Artrya Limited (AYA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$764 Proxy Form - Annual General Meeting 13 Oct 2022 6:43PM $0.660 $4.690 risen by 610.61%
$764 Notice of Annual General Meeting 13 Oct 2022 6:42PM $0.660 $4.690 risen by 610.61%
$764 Artrya Annual Report 2022 13 Oct 2022 6:40PM $0.660 $4.690 risen by 610.61%
$764 Appointment of Company Secretary 7 Oct 2022 10:15AM $0.610 $4.690 risen by 668.85%
$764 Notification regarding unquoted securities - AYA 20 Sep 2022 5:49PM $0.650 $4.690 risen by 621.54%
$764 Application for quotation of securities - AYA 15 Sep 2022 8:16AM $0.600 $4.690 risen by 681.67%
$764 Appendix 4G and Corporate Governance Statement 31 Aug 2022 1:01PM $0.785 $4.690 risen by 497.45%
$764 Appendix 4E and Annual Financial Report 30 June 2022 31 Aug 2022 1:00PM $0.785 $4.690 risen by 497.45%
$764 Artrya Strengthens Board with US-based Director 1 Aug 2022 9:22AM $0.710 $4.690 risen by 560.56%
$764 Updated Appendix 4C for Q4 FY22 27 Jul 2022 6:23PM $0.690 $4.690 risen by 579.71%
$764 Quarterly Activity Report and Appendix 4C for Q4 FY22 26 Jul 2022 9:10AM $0.720 $4.690 risen by 551.39%
$764 Quarterly Results Conference Call 20 Jul 2022 8:20AM $0.820 $4.690 risen by 471.95%
$764 Notification regarding unquoted securities - AYA 7 Jul 2022 6:42PM $0.670 $4.690 risen by 600%
$764 Notification regarding unquoted securities - AYA 4 Jul 2022 6:46PM $0.700 $4.690 risen by 570%
$764 Notification regarding unquoted securities - AYA 4 Jul 2022 6:33PM $0.700 $4.690 risen by 570%
$764 Change of Director's Interest Notice - Bernie Ridgeway 1 Jul 2022 8:42AM $0.650 $4.690 risen by 621.54%
$764 Change of Director's Interest Notice - John Barrington 30 Jun 2022 6:39PM $0.650 $4.690 risen by 621.54%
$764 Change of Director's Interest Notice - Bernie Ridgeway 24 Jun 2022 3:26PM $0.575 $4.690 risen by 715.65%
$764 Artrya Appoints Accomplished American Physician as CMO 20 Jun 2022 9:38AM $0.460 $4.690 risen by 919.57%
$764 Conference Call - Update on US FDA Application 17 Jun 2022 8:18AM $0.560 $4.690 risen by 737.50%
$764 Update on US FDA Application for Artrya Salix 16 Jun 2022 3:55PM $0.560 $4.690 risen by 737.50%
$764 Change of Director's Interest Notice - John Barrington 18 May 2022 8:18AM $0.810 $4.690 risen by 479.01%
$764 Artrya Signs First U.S. Hospital Clinical Partnership 9 May 2022 8:39AM $0.700 $4.690 risen by 570%
$764 Application for quotation of securities - AYA 26 Apr 2022 8:25AM $1.050 $4.690 risen by 346.67%
$764 Quarterly Activity Report and Appendix 4C for Q3 FY22 19 Apr 2022 8:31AM $1.050 $4.690 risen by 346.67%

276 - 300 of 504 results

Page 12 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.